Clinical efficacy of submucosal tunneling endoscopic resection for esophageal leiomyoma in 18 patients

Guohua Li,Guoping Du

DOI: https://doi.org/10.3760/cma.j.issn.1674-1927.2015.02.017

2015-01-01

Abstract:Objective To analysis the clinical efficacy of submucosal tunneling endoscopic resection(STER)for submucosal tumors of the esophagus. Methods The clinical date of 18 patients with submucosal esophageal leiomyoma who received STER in our department between March 2012 and June 2013 were retrospectively reviewed. The operative time,the number of hemoclips,the length of hospital stay,medical expenses and postoperative complications were recorded. During follow?up at 3,6 and 12 months after surgery,we also recorded the wound healing,residual lesions and tumor recurrence in each patient. Results 18 patients underwent STER uneventfully,and all lesions were completely removed. For these patients,the operative time was(59.8 ± 15.2)min,the number of hemoclips placement was 6.9 ± 2.1, the length of hospital stay was(6.3 ± 1.4)days and the medical expenses were(8 950 ± 2 230)Yuan. No serious postoperative complications occurred except for 2 cases of subcutaneous emphysema of the neck after surgery. All patients were followed up at 3,6 and 12 months after surgery. At these time points,gastroscopy showed good healing of the surgical wound surface,and no residual lesions or tumor recurrence were detected by ultrasound endoscopy. Conclusion STER can be advantageous for widespread use in clinical practicing owing to short operative time,small?size wound surface,few complications and early postoperative recovery.